Home
Centers
Meetings
Committees
Staff
Documents
Database
Studies

Publications

Links
  About SOCA   About CC   Contact Us   Public
Data Access 		  Banked
Specimens/Data

 

Publications

LSOCA   MACRT
FGCRT   GCCRT
CRRT   SOCA
HPCRT    

LSOCA Credit Roster (Nov 2012)

Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

  1. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial:   1. Rationale, design, and methods.  Controlled Clin Trials 13:22-39, 1992.  PMID: 1315661
  2. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.  New Eng J Med, 326:213-220, 1992.  PMID: 1345799
  3. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Foscarnet-Ganciclovir CMV Retinitis Trial:  4. Visual outcomes.  Ophthalmology 101:1250-1261, 1994.  PMID: 8035989
  4. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial.  Arch Int Med 155:65-74 1995.  PMID: 7802522
  5. Studies of Ocular Complications of AIDS Research Group; in collaboration with AIDS Clinical Trials Group:  Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis.  J Infect Dis 172:613-621, 1995.  PMID: 7658051
  6. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Assessment of cytomegalovirus retinitis:  clinical evaluation vs centralized grading of fundus photographs.  Arch Ophthalmol 114:791-805, 1996.  PMID: 8660161
  7. Wu AW, Coleson LC, Holbrook JT, Jabs DA; for the Studies of Ocular Complication of AIDS Research Group:  Measuring visual function and quality of life in patients with cytomegalovirus retinitis:  Development of a questionnaire.  Arch Ophthalmol.  114:841-847, 1996.  PMID: 8660168
  8. Studies of the Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Clinical vs. photographic assessment of treatment of cytomegalovirus retinitis.  Foscarnet- Ganciclovir Cytomegalovirus Retinitis Trial Report 8.  Arch Ophthalmol, 114:848-855, 1996.  PMID: 8660169
  9. Studies of Ocular Complications of AIDS; in collaboration with the AIDS Clinical Trials Group:  Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir.  J Infect Dis, 176:50-58, 1997.  PMID: 9207349
  10. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group.  Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis:  The Foscarnet- Ganciclovir Cytomegalovirus Retinitis Trial.  Am J Ophthalmol, 124:61-70, 1997.  PMID: 9222234
  11. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial:  5. Clinical features of cytomegalovirus retinitis at diagnosis.  Am J Ophthalmol 124:141-157, 1997.  PMID: 9262538
  12. Wu AW, Revicki DA, Jacobson D, Malitz FE:  Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).  Qual Life Res 6:481-493, 1997.  PMID: 9330549
  13. Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert CL and Reshef DS; for the Studies of Ocular Complications of AIDS Research Group:  Risk factors for advancement of cytomegalovirus retinitis in patients with AIDS.  Arch Ophthalmol 118:1196-1204, 2000.  PMID: 10980764

Back to the TOP of the page

CMV Retinitis Retreatment Trial (CRRT)

  1. Studies of the Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Combination foscarnet and ganciclovir therapy vs. monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS:  The Cytomegalovirus Retreatment Trial.  Arch Ophthalmol 114:23-33, 1996.  PMID: 8540847
  2. Martin BK, Gilpin AMK, Jabs DA, and Wu AW; for the Studies of Ocular Complications of AIDS Research Group:  Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis.  J Clin Epidemiol 54:376-386, 2001.  PMID: 11305288

Back to the TOP of the page

HPMPC Peripheral CMV Retinitis Trial (HPCRT)

  1. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC Peripheral Cytomegalovirus Retinitis Trial.  A randomized, controlled trial.  Ann Intern Med 126:264-274, 1997.  PMID: 9036798
  2. Jabs DA, Meinert CL, Lalezari JP:  Letter to the Editor (response) regarding cidofovir for cytomegalovirus retinitis (HPCRT).   Ann Intern Med 1997;127:490-491.
  3. The Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis:  The HPMPC Peripheral Cytomegalovirus Retinitis Trial.  AIDS 14:1571-1581, 2000.   PMID: 10983644

Back to the TOP of the page

Monoclonal Antibody CMV Retinitis Trial (MACRT)

  1. Studies of Ocular Complications of AIDS Research Group; in collaboration with the AIDS Clinical Trials Group:  MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome:  The Monoclonal Antibody Cytomegalovirus Retinitis Trial.  Arch Ophthalmol 115:1528-1536, 1997.  PMID: 9400786
  2. Jabs DA, Kaplan Gilpin AM, Min YI, Erice A, Kempen JH and Quinn TC; for the Studies of Ocular Complications of AIDS Research Group:  HIV and CMV viral load and clinical outcomes in patients with AIDS and cytomegalovirus retinitis: The Monoclonal Antibody Cytomegalovirus Retinitis Trial.  AIDS 16:877-887 2002.   PMID: 12232843
  3. Davidson M, Min Y, Holbrook JT, Quinn T, Murphy R, Jabs DA, Jacobson M, and Meinert CL; for the Studies of Ocular Complications of AIDS Research Group:  The Influence of filgrastim (granulocyte colony- stimulating factor on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.  J Inf Dis 186:1013-8, 2002.  PMID: 12232843
  4. Gilpin AM, Holbrook JT, Jabs DA, Meinert CL; for the Studies of Ocular Complications of AIDS Research Group:  Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial.  Controlled Clin Trials 24(1):92-98, 2003.  PMID: 12559647

Back to the TOP of the page

Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT)

  1. The Studies of Ocular Complications of AIDS Research Group (SOCA); in collaboration with the AIDS Clinical Trials Group:  The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome:  The Ganciclovir Cidofovir CMV Retinitis Trial.  Am J Ophthalmol 131:457-467, 2001.  PMID: 11292409
  2. Dunn JP, Van Natta ML, Foster G, Kuppermann B, Martin DF, Zong A, and Jabs DA; for the Studies of Ocular Complications of AIDS Research Group.  Complications of Ganciclovir implant surgery in patients with CMV retinitis.  Retina 24(1):41-50, 2004.   PMID: 15076943

Back to the TOP of the page

Longitudinal Study of Ocular Complications of AIDS (LSOCA)

  1. Jabs DA, Van Natta ML, Kempen JH, Pavan PR, Lim J, Murphy R, Hubbard L; for the Studies of Ocular Complications of AIDS Research Group:   Characteristics of patients with CMV retinitis in the era of highly active anti-retroviral therapy (HAART).  Am J Ophthalmol 133:48-61, 2002.  PMID: 11755839
  2. Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:   The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy.  Ophthalmology 110(5):987-995, 2003.   PMID: 12750102
  3. Marshall BC, Jacobson MA, Adler SP; in collaboration with the Studies of Ocular Complications of AIDS Research Group:  Avidity of Antibodies to Cytomegalovirus in HIV Seropositive Patients with and without CMV Retinitis.  Viral Immunol 17(1):101-8, 2004.  PMID: 15018666
  4. Jacobson MA, Maecker HT, Orr PL, D'Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM; for the Adults AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group.  Results of a CMV-Specific CD8+/IFNγ+Cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis.   J Infect Dis 189:1362-1373, 2004.   PMID: 15073672
  5. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; for the Studies of Ocular Complications of AIDS Research Group.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy:  1. Retinitis progression.   Ophthalmology 111:2224-2231, 2004.  PMID: 15582078
  6. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; for the Studies of Ocular Complications of AIDS Research Group.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy:  2. Second eye involvement and retinal detachment.  Ophthalmology 111:2232-2239, 2004.  PMID: 15582079
  7. Weinberg DV, Holbrook JT, Hubbard LD, Davis MD, Jabs DA, Holland GN; for the Studies of Ocular Complications of AIDS Research Group.  Clinician versus Reading Center Assessment of cytomegalovirus retinitis lesion size.  Ophthalmology 112:559-566, 2005.   PMID: 15808244
  8. Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL; for the Studies of Ocular Complications of AIDS Research Group:  Risk Factors for Mortality in Patients with AIDS in the era of HAART.   Ophthalmology 112:771-779, 2005.  PMID: 15878056
  9. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW; Ocular Complications of AIDS Research Group:  The impact of anemia on energy and physical functioning in individuals with AIDS.  Arch Intern Med 165(19):2229-2236, 2005.  PMID: 16246988
  10. Kempen JH, Min Y-I, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:  Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.  Ophthalmology 113(4):684-694, 2006.  PMID: 16581429
  11. Brown DM, Thorne JE, Foster GL, Duncan JL, Brune LM, Mũnana A, Meinert CL, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:  Factors affecting attrition of patients with AIDS.   AIDS Care 18(7):821-829, 2006.  PMID: 16971294
  12. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL; for the Studies of Ocular Complications of AIDS (SOCA) Research Group:   Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy.  Ophthalmology 113(8):1432-40, 2006.   PMID: 16766032
  13. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL; for the Studies of Ocular Complications of AIDS (SOCA) Research Group:   Causes of visual acuity loss among patients with AIDS and CMV in the era of HAART.  Ophthalmology 113:1441-1445, 2006.   PMID: 16781775
  14. Shah KH, Holland GH, Yu F, Van Natta M, Nusinowitz S; in collaboration with the Studies of Ocular complications of AIDS (SOCA) Research Group:   Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy.  Am J Ophthalmol 142:284-292, 2006.  PMID: 16876510
  15. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Van Natta ML, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA; Studies of Ocular Complications of AIDS Research Group:  Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon-gamma and interleukin-2 and have a CD8+ cell early maturation phenotype.  J Infect Dis 94(11):1537-46, 2006.  PMID: 17083038
  16. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL; for the Ocular Complications of AIDS Research Group:  The effect of cytomegalovirus (CMV) retinitis on the risk of visual acuity loss among patients with AIDS.  Ophthalmology 114:591-598, 2007.  PMID: 17123624
  17. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD; for the Studies of the Ocular Complications of AIDS Research Group:  The Longitudinal Study of the Ocular Complications of AIDS:  1. Ocular diagnoses at enrollment.  Ophthalmology 114:780-786. 2007.  PMID: 17258320
  18. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD; for the Studies of the Ocular Complications of AIDS Research Group:  The Longitudinal Study of the Ocular Complications of AIDS:  2. Ocular examination results at enrollment.  Ophthalmology 114:787-793, 2007.  PMID: 17210182
  19. Jacobson, MA, Tan QX, Girling V. Poon C, Van Natta ML, Jabs DA, Inokuma M, Maecker HT, Bredt B, and Sinclair E; for the Studies of Ocular Complications of AIDS Research Group:  Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.  Clin Infect Dis 46:458-466, 2008.  PMC: 2666016
  20. Freeman WR, Van Natta ML, Jabs DA, Sample PA, Sadun AA, Thorne J, Shah KH, Holland GN; for the SOCA Research Group:  Vision function in HIV- infected individuals without retinitis:  Report of the Studies of Ocular Complications of AIDS Research Group.  Am J Ophthalmol 45:453-462, 2008.  PMC: 2959724
  21. Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:  AIDS and ophthalmology.  Arch Ophthalmol 126:1143-1146, 2008.  PMID: 18695113
  22. Hendrickson SL, Jabs DA, Van Natta M, Lewis RA, Wallace DC, O'Brien SJ:  Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients.  J Acquir Immune Defic Syndr 53:451-455, 2010.  PMID: 20098332
  23. Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O’Brien SJ; for the SOCA Research Group:  Effect of host genetics on CMV retinitis occurrence in patients with AIDS.  J Infect Dis 202:606-613, 2010.  PMC: 2932829
  24. Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; for the Studies of the Ocular Complications of AIDS Research Group:  Course of Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy:  Five-year Outcomes.  Ophthalmology 117(11):2152-61, 2010.  PMC: 2963687
  25. Holland GN, Kappel PJ, Van Natta ML, Palella FJ, Lyon AT, Shah KH, Pavan PR, Jabs DA; on behalf of the Studies of the Ocular Complications of AIDS Research Group:  Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome.   Am J Ophthalmol 149:807-816, 2010.   PMID: 20399927
  26. Sezgin E, Hendrickson SL, Jabs DA, Van Natta M, Lewis RA, Troyer JL, O’Brien SJ; for the SOCA Research Group:  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.   J Acquir Immune Defic Syndr 54:343-351, 2010.  PMC: 2908809
  27. Puhan M, Van Natta ML, Pallela FJ, Addessi A, Meinert CL:   Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: Temporal changes and risk factors.   Clin Inf Dis 51:947–956, 2010.   PMC: 2943970
  28. Sezgin E, Van Natta M, Ahuja A, Lyon A, Srivastava S, Troyer JL, O’Brien SJ, Jabs DA; for the SOCA Research Group:  Association of Host Genetic Risk Factors with the Course of Cytomegalovirus Retinitis in Patients Infected with HIV.  Am J Ophthalmol 151:999-1006, 2011.  PMC: 3103625
  29. Puhan M, Ahuja A, Van Natta ML, Ackatz LE, Meinert CL for the Studies of Ocular Complications of AIDS Research Group:  Interviewer versus self-administered health-related quality of life questionnaires - Does it matter?   Health Qual Life Outcomes 9:30, 2011.   PMC: 3100232
  30. Thorne JE, Van Natta ML, Jabs DA, Duncan J, Srivastava S; for the Studies of the Ocular Complications of AIDS Research Group:  Visual field loss among patients with cytomegalovirus retinitis.  Ophthalmology 118:895-901, 2011.  PMC: 3087851
  31. Holbrook JT, Colvin R, Van Natta ML, Thorne JE, Bardsley M, Jabs DA; for the Studies of Ocular Complications of AIDS (SOCA) Research Group:   Evaluation of the United States Public Health Service guidelines for discontinuation of anti-cytomegalovirus therapy after immune recovery in patients with CMV retinitis.  Am J Ophthalmol 154(4):628-637, 2011.  PMC: 3185165
  32. Gangaputra S, Won Pak J, Peng Q, Hubbard LD, Thayer D, Krason Z, Joyce J, Danis RP; for the Studies of Ocular Complications of AIDS Research Group:  Transition from film to digital fundus photography in the Longitudinal Studies of Ocular Complications of AIDS.   Retina 32:600-605, 2012.  PMID: 21857393
  33. Gangaputra S, Kalyani PS, Fawzi AA, Van Natta ML, Hubbard LD, Danis RP, Thorne JE, Holland GN; on behalf of the Studies of Ocular Complications of AIDS Research Group:  Retinal vessel caliber among people with AIDS:  Relationship with disease-associated factors and mortality.  Am J Ophthalmol 153:434-444, 2012.  PMC: 3289046
  34. Kalyani PS, Fawzi AA, Gangaputra S, Van Natta ML, Hubbard LD, Danis RP, Thorne JE, Holland GN; on behalf of the Studies of Ocular Complications of AIDS Research Group:  Retinal vessel caliber among people with AIDS:  Relationships with visual function.  Am J Ophthalmol 153:428-433, 2012  PMID: 22019221
  35. Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; for the Studies of Ocular Complications of AIDS Research Group:  Incidence of cytomegalovirus retinitis in the era of highly active antiretrovial therapy.  Am J Ophthalmol 153:1016-1024, 2012.  PMC: 3358595
  36. Limou S, Delaneau O, van Manen D, An P, Sezgin E, Le Clerc S, Coulonges C, Troyer JL, Veldink JH, van den Berg LH, Spadoni JL, Taing L, Labib T, Montes M, Delfraissy JF, Schachter F, O'Brien SJ, Buchbinder S, Van Natta ML, Jabs DA, Froguel P, Schuitemaker H, Winkler CA, Zagury JF:  Multicohort genome wide association study reveals a new signal of protection against HIV-1 acquisition.  J Infect Dis 205:1155-1162, 2012.  PMC: 3295605
  37. Kalyani PS, Holland GN, Fawzi AA, Arantes TEF, Sadun AA; in collaboration with the Studies of Ocular Complication of AIDS Research Group:   Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection.   Am J Ophthalmol 153(4):734-742, 2012.   PMID: 22245459
  38. Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:   Mortality in HCV-infected patients with a diagnosis of AIDS in the era of combination anti-retroviral therapy.  Clin Infect Dis 55(1):137-144, 2012.  PMC: 336965
  39. Kempen JH, Sugar EA, Lyon AT, Lewis RA, Jabs DA, Heinemann MH, Dunn JP for the Studies of Ocular Complications of AIDS:  Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome.  Ophthalmology 119:2343-2350, 2012.  PMC: 3650486
  40. Kozak I, Ahuja A, Gangaputra S, Van Natta ML, Thorne JE, Freeman W for the Studies of Ocular Complications of AIDS Research Group:  Optic nerve head morphology and visual field function in patients with AIDS and without infectious retinitis.  Ocul Immunol Inflamm 20(5):342-348, 2012.  PMC: 4164231
  41. Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon A for the Studies of the Ocular Complications of AIDS Research Group:  Non-cytomegalovirus ocular opportunistic infections in patients with AIDS.  Am J Ophthalmol 155(2):206-212, 2013.  PMID: 23068916
  42. Jabs DA, Ajuja A, Van Natta ML, Dunn JP, Yeh S for the Studies of Ocular Complications of AIDS Research Group:  Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.  Ophthalmology 120(6):1262-1270, 2013.  PMC: 3660467
  43. Krauskopf K, Van Natta ML, Danis RP, Gangaputra S, Ackatz L, Addessi A, Federman AD, Branch AD, Meinert CL, Jabs DA for the Studies of Ocular Complications of AIDS Research Group:  Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy.  J Int Assoc Provid AIDS Care 12(5):325-333, 2013.  PMC: 4100586
  44. Branch AD, Drye LT, Van Natta ML, Sezgin E, Fishman SL, Dieterich DT, Meinert CL, and Jabs DA:  Evaluation of Hepatitis C Virus as a Risk Factor for HIV-Associated Neuroretinal Disorder.  Clin Infect Dis 57(11):1618-1625, 2013.  PMC: 3814824
  45. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, and Deeks SG:  HIV-Infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.  PLOS Pathogens 10(5):e1004078, 2014.  PMC: 4022662
  46. Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, Deeks SG, Meinert CL, Van Natta M, Jabs DA, Lederman MM:  Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.  J Infect Dis 210(8):1228-38, 2014.  PMC: 4192038
  47. Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta ML, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, and Hunt PW:  Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.  J Infect Dis 210(3):374-382, 2014.  doi: 10.1093/infdis/jiu109.   PMID: 24585893
  48. Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne J for the Studies of Ocular Complications of AIDS Research Group:  The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.  Invest Ophthalmol Vis Sci 55(7):4304-4312, 2014.  PMC: 4098061
  49. Kempen JH, Sugar EA, Varma R, Dunn JP, Heinemann MH, Jabs DA, Lyon AT, Lewis RA for Studies of Ocular Complications of AIDS Research Group:  Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections.  Ophthalmology 121(12):2317-2324, 2014.  PMC: 4252252
  50. Jabs DA, Drye L, Van Natta ML, Thorne JE, Holland GN, Studies of Ocular Complications of AIDS Research Group:  Incidence and long-term outcomes of the human immunodeficiency virus neuroretinal disorder in patients with AIDS.  Ophthalmology 122(4): 760-768, 2015.   PMC: 4372475
  51. Jabs DA, Van Natta ML, Sezgin E, Pak JW, Danis R, Studies of Ocular Complications of AIDS Research Group:  Prevalence of intermediate-stage age-related macular degeneration in patients with the acquired immunodeficiency syndrome.  Am J Ophthalmol 159(6):1115-1122, 2015.
  52. Jabs DA, Ahuja A, Van Natta ML, Lyon AT, Yeh S, Danis R for the Studies of Ocular Complications of AIDS Research Group:  Long-term outcomes of cytomegalovirus retinitis in the era of modern antiretroviral therapy: Results from a United States Cohort.  Ophthalmology 122(7):1452-1463, 2015.  PMC: 4485590
  53. Ashraf DC, May KP, Holland GN, Van Natta ML, Wu AW, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group:  Relationship between human immunodeficiency virus neuroretinal disorder and vision-specific quality of life among people with AIDS.  Ophthalmology (Forthcoming).
  54. Sezgin E, Van Natta ML, Thorne JE, Puhan MA, Jabs DA on behalf of the Studies of Ocular Complications of AIDS (SOCA) Research Group:  Secular trends in AIDS defining opportunistic infections, cancers, and mortality in patients with AIDS in the cART era. (To Be Submitted).
  55. Jabs DA, Van Natta ML, Danis R, for the Studies of Ocular Complications of AIDS Research Group:  Cytomegalovirus retinitis among patients with the acquired immune deficiency syndrome initiating antiretroviral therapy.   (To Be Submitted).
  56. Jabs AW, Jabs DA, Van Natta ML, Meinert CL, Palella F for the Studies of Ocular Complications of AIDS (SOCA) Research Group:  Insurance status and mortality among patients with AIDS.  (To Be Submitted).

Back to the TOP of the page

Studies of Ocular Complications of AIDS (SOCA)

  1. Holbrook JT, Meinert CL, Van Natta ML, Davis MD, Hubbard L, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:   Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients.  Arch Ophthalmol 119:554-563, 2001.  PMID: 11296021
  2. Holbrook JT, Meinert CL, Jabs DA; for the Studies of Ocular Complications of AIDS Research Group:  Patient notification and followup after suspension of treatment protocols:  Experience from four clinical trials of treatments for AIDS-related CMV Retinitis.   Controlled Clin Trials 22:62-68, 2002.   PMID: 11165425
  3. Davidson M, Min Y, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, and Meinert CL; for the Studies of Ocular Complications of AIDS Research Group:  Use of filgrastim (G-CSF) as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis.  AIDS 16:757-765, 2002.  PMID: 11964532
  4. Holbrook JT, Jabs DA, Lewis RA, Weinberg D, Davis MD, Friedberg D; for the Studies of Ocular Complications of AIDS Research Group.  Visual loss in patients with cytomegalovirus retinitis and AIDS before wide spread availability of highly active antiretroviral therapy.  Arch Ophthalmol 121(1):99-107, 2003.  PMID: 12523893

Back to the TOP of the page

Other Publications

These books are available at http://www.amazon.com

Meinert CL:   Clinical Trials: Design, Conduct, and Analysis (Second Edition).  Oxford University Press, New York, NY, 2012.

Meinert CL:  Clinical Trials Dictionary: Terminology and Usage Recommendations
(Second Edition).  John Wiley & Sons, New York, NY, 2012.

Piantadosi S:  Clinical Trials: A Methodologic Perspective (Second Edition).  
John Wiley & Sons, New York, NY, 2005.

Meinert CL:  Clinical Trials: An Insider's Guide to Clinical Trials.  Oxford University Press, New York, NY, 2011.

Meinert CL:  Clinical Trials Handbook: Design and Conduct.   John Wiley & Sons, New York, NY, 2012.

Back to the TOP of the page

 

 

Last updated: Tuesday, August 18, 2015